RAMQ has informed PAAB that:
Additionally, the layout must not suggest that the authorized Federal indication is the reimbursement criteria (except where this is indeed the case).
When applying the above provisions, please keep in mind that off-label criteria are not acceptable in drug advertising per s3.1.
Additional consideration: RAMQ prefers that a URL linked to the RAMQ webpage containing the PDF “Liste des médicaments”, along with the date of access, also be presented somewhere within the piece (e.g. reference list).
Note that this advisory currently applies only to RAMQ and is supplemental the general provisions in the following PAAB advisories:
PAAB reviewing staff have been instructed to immediately begin applying this advisory to preclearance activities.